Immuno Oncology Assays Market

1. Executive Summary
    1.1. Key Market Insights  

2. Introduction            
    2.1. Study Objectives        
    2.2. Market Definition        
           2.2.1. Market Covered    
           2.2.2. Regional Coverage    
           2.2.3. Study Years & Currency    
    2.3. Market Stakeholders        
    2.4. Key Questions this Study will Answer        
    2.5. GMI Research’s Approach & Methodology  
           2.5.1. Research Data
           2.5.2. Primary Data
           2.5.3. Demand Side and Supply Side Analysis
           2.5.4. Market Size Estimation
           2.5.5. Research Assumptions

3. Global Immuno Oncology Assays Market- Overview            
    3.1. Introduction         
    3.2. Market Segmentation        
    3.3. Value Chain Analysis        
    3.4. Market Drivers        
    3.5. Market Restraints        
    3.6. Market Trends      

4. Global Immuno Oncology Assays Market Revenue Forecast till 2030     

5. Global Immuno Oncology Assays Market by Product & Service Revenue Forecast till 2030            
    5.1. Reagents and Antibodies
    5.2. Instruments
    5.3. Software
    5.4. Consumables and Accessories 

6. Global Immuno Oncology Assays Market by Technology Revenue Forecast till 2030            
    6.1. Polymerase Chain Reaction
    6.2. Immunoassay
    6.3. Next-Generation Sequencing
    6.4. In Situ Hybridization
    6.5. Flow Cytometry 

7. Global Immuno Oncology Assays Market by Indication Revenue Forecast till 2030            
    7.1. Lung Cancer
    7.2. Breast Cancer
    7.3. Colorectal Cancer
    7.4. Bladder Cancer
    7.5. Melanoma
    7.6. Others 

8. Global Immuno Oncology Assays Market by Application Revenue Forecast till 2030            
    8.1. Research Applications
    8.2. Clinical Diagnostic

9. Global Immuno Oncology Assays Market by Region Forecast till 2030
    9.1. North America Immuno Oncology Assays Market Revenue Forecast till 2030 
    (Option 1: As a part of the free 25% customization)
           9.1.1. North America Immuno Oncology Assays Market by Product & Service
                     9.1.1.1. Reagents and Antibodies
                     9.1.1.2. Instruments
                     9.1.1.3. Software
                     9.1.1.4. Consumables and Accessories 
           9.1.2. North America Immuno Oncology Assays Market by Technology
                     9.1.2.1. Polymerase Chain Reaction
                     9.1.2.2. Immunoassay
                     9.1.2.3. Next-Generation Sequencing
                     9.1.2.4. In Situ Hybridization
                     9.1.2.5. Flow Cytometry 
           9.1.3. North America Immuno Oncology Assays Market by Indication
                     9.1.3.1. Lung Cancer
                     9.1.3.2. Breast Cancer
                     9.1.3.3. Colorectal Cancer
                     9.1.3.4. Bladder Cancer
                     9.1.3.5. Melanoma
                     9.1.3.6. Others 
           9.1.4. North America Immuno Oncology Assays Market by Application
                     9.1.4.1. Research Applications
                     9.1.4.2. Clinical Diagnostic
           9.1.5. US Immuno Oncology Assays Market All-Up
           9.1.6. Canada Immuno Oncology Assays Market All-Up
    9.2. Europe Immuno Oncology Assays Market Revenue Forecast till 2030 
    (Option 2: As a part of the free 25% customization)
           9.2.1. Europe Immuno Oncology Assays Market by Product & Service
                     9.2.1.1. Reagents and Antibodies
                     9.2.1.2. Instruments
                     9.2.1.3. Software
                     9.2.1.4. Consumables and Accessories 
           9.2.2. Europe Immuno Oncology Assays Market by Technology
                     9.2.2.1. Polymerase Chain Reaction
                     9.2.2.2. Immunoassay
                     9.2.2.3. Next-Generation Sequencing
                     9.2.2.4. In Situ Hybridization
                     9.2.2.5. Flow Cytometry 
           9.2.3. Europe Immuno Oncology Assays Market by Indication
                     9.2.3.1. Lung Cancer
                     9.2.3.2. Breast Cancer
                     9.2.3.3. Colorectal Cancer
                     9.2.3.4. Bladder Cancer
                     9.2.3.5. Melanoma
                     9.2.3.6. Others 
           9.2.4. Europe Immuno Oncology Assays Market by Application
                     9.2.4.1. Research Applications
                     9.2.4.2. Clinical Diagnostic
           9.2.5. UK Immuno Oncology Assays Market All-Up
           9.2.6. Germany Immuno Oncology Assays Market All-Up
           9.2.7. France Immuno Oncology Assays Market All-Up
           9.2.8. Spain Immuno Oncology Assays Market All-Up
           9.2.9. Rest of Europe Immuno Oncology Assays Market All-Up
    9.3. Asia-Pacific Immuno Oncology Assays Market Revenue Forecast till 2030 
    (Option 3: As a part of the free 25% customization) 
           9.3.1. Asia-Pacific Immuno Oncology Assays Market by Product & Service
                     9.3.1.1. Reagents and Antibodies
                     9.3.1.2. Instruments
                     9.3.1.3. Software
                     9.3.1.4. Consumables and Accessories 
           9.3.2. Asia-Pacific Immuno Oncology Assays Market by Technology
                     9.3.2.1. Polymerase Chain Reaction
                     9.3.2.2. Immunoassay
                     9.3.2.3. Next-Generation Sequencing
                     9.3.2.4. In Situ Hybridization
                     9.3.2.5. Flow Cytometry 
           9.3.3. Asia-Pacific Immuno Oncology Assays Market by Indication
                     9.3.3.1. Lung Cancer
                     9.3.3.2. Breast Cancer
                     9.3.3.3. Colorectal Cancer
                     9.3.3.4. Bladder Cancer
                     9.3.3.5. Melanoma
                     9.3.3.6. Others 
           9.3.4. Asia-Pacific Immuno Oncology Assays Market by Application
                     9.3.4.1. Research Applications
                     9.3.4.2. Clinical Diagnostic
           9.3.5. China Immuno Oncology Assays Market All-Up
           9.3.6. India Immuno Oncology Assays Market All-Up
           9.3.7. Japan Immuno Oncology Assays Market All-Up
           9.3.8. Rest of APAC Immuno Oncology Assays Market All-Up
    9.4. RoW Immuno Oncology Assays Market Revenue Forecast till 2030
    (Option 4: As a part of the free 25% customization)  
           9.4.1. RoW Immuno Oncology Assays Market by Product & Service
                     9.4.1.1. Reagents and Antibodies
                     9.4.1.2. Instruments
                     9.4.1.3. Software
                     9.4.1.4. Consumables and Accessories 
           9.4.2. RoW Immuno Oncology Assays Market by Technology
                     9.4.2.1. Polymerase Chain Reaction
                     9.4.2.2. Immunoassay
                     9.4.2.3. Next-Generation Sequencing
                     9.4.2.4. In Situ Hybridization
                     9.4.2.5. Flow Cytometry 
           9.4.3. RoW Immuno Oncology Assays Market by Indication
                     9.4.3.1. Lung Cancer
                     9.4.3.2. Breast Cancer
                     9.4.3.3. Colorectal Cancer
                     9.4.3.4. Bladder Cancer
                     9.4.3.5. Melanoma
                     9.4.3.6. Others 
           9.4.4. RoW Immuno Oncology Assays Market by Application
                     9.4.4.1. Research Applications
                     9.4.4.2. Clinical Diagnostic
           9.4.5. Brazil Immuno Oncology Assays Market All-Up
           9.4.6. South Africa Immuno Oncology Assays Market All-Up
           9.4.7. Saudi Arabia Immuno Oncology Assays Market All-Up
           9.4.8. UAE Immuno Oncology Assays Market All-Up
           9.4.9. Rest of world (remaining countries of the LAMEA region) Immuno Oncology Assays Market All-Up

10. Competitive Landscape Analysis
    10.1. Porter’s Five Forces Analysis
    10.2. Industry – Competitive Landscape
    10.3. Market Presence (Intensity Mapping)
    10.4. Key Strategic Market Developments 

11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
    11.1. Thermo Fisher Scientific Inc.
           11.1.1. Company Overview    
           11.1.2. Key Executives 
           11.1.3. Footprint & Employee Strength 
           11.1.4. Product Offerings    
           11.1.5. Financials
           11.1.6. Key Company Developments 
    11.2. F. Hoffmann-La Roche Ltd.
           11.2.1. Company Overview    
           11.2.2. Key Executives   
           11.2.3. Footprint & Employee Strength
           11.2.4. Product Offerings
           11.2.5. Financials
           11.2.6. Key Company Developments
    11.3. Illumina, Inc.
           11.3.1. Company Overview    
           11.3.2. Key Executives
           11.3.3. Footprint & Employee Strength
           11.3.4. Product Offerings
           11.3.5. Financials
           11.3.6. Key Company Developments
    11.4. Merck KGaA
           11.4.1. Company Overview    
           11.4.2. Key Executives
           11.4.3. Footprint & Employee Strength
           11.4.4. Product Offerings
           11.4.5. Financials
           11.4.6. Key Company Developments
    11.5. Agilent Technologies, Inc.
           11.5.1. Company Overview    
           11.5.2. Key Executives   
           11.5.3. Footprint & Employee Strength
           11.5.4. Product Offerings
           11.5.5. Financials
           11.5.6. Key Company Developments
    11.6. Abbott
           11.6.1. Company Overview    
           11.6.2. Key Executives
           11.6.3. Footprint & Employee Strength
           11.6.4. Product Offerings
           11.6.5. Financials
           11.6.6. Key Company Developments
    11.7. Sartorius AG
           11.7.1. Company Overview
           11.7.2. Key Executives
           11.7.3. Footprint & Employee Strength
           11.7.4. Product Offerings
           11.7.5. Financials
           11.7.6. Key Company Developments    
    11.8. Nanostring Technologies, Inc.
           11.8.1. Company Overview
           11.8.2. Key Executives 
           11.8.3. Footprint & Employee Strength
           11.8.4. Product Offerings
           11.8.5. Financials
           11.8.6. Key Company Developments    
    11.9. HTG Molecular Diagnostics, Inc.
           11.9.1. Company Overview
           11.9.2. Key Executives 
           11.9.3. Footprint & Employee Strength
           11.9.4. Product Offerings
           11.9.5. Financials
           11.9.6. Key Company Developments   
    11.10. Perkinelmer, Inc.
           11.10.1. Company Overview
           11.10.2. Key Executives 
           11.10.3. Footprint & Employee Strength
           11.10.4. Product Offerings
           11.10.5. Financials
           11.10.6. Key Company Developments   

12. About GMI Research

*Details on Financials might not be available in case of unlisted/private companies.

*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.